TORSKAL

About:

TORSKAL is an international biotechnology company, a pioneer of green nanotechnology that develops gold nanoparticles for cancer therapy.

Website: https://www.torskal.com/

Twitter/X: Torskal_Nano

Description:

As a pioneer of green nanotechnology in the world, we have developed gold nanoparticles by means of a patented and environmentally friendly process, using medicinal plant extracts from the Indian ocean to treat cancer. Our Nanotheranostics Project (NT1) which treats skin cancers by photothermal therapy is entering phase 1 human clinical trials by the end of 2021. It will be followed by our second project, Deep Cancer (NT2), which aims to develop new nanotheranostics for the treatment of deep cancers such as prostate and pancreatic cancers.

Total Funding Amount:

2M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Saint-denis, Ile-de-France, France

Founded Date:

2015-01-01

Contact Email:

contact(AT)torskal.com

Founders:

Anne-Laure Morel

Number of Employees:

11-50

Last Funding Date:

2020-05-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai